Using fast tests on tumor tissue to pick treatment for rare brain tumors that came back
Original title: Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, so it is still being tested in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a fast way to match treatment to a person's own tumor.
Who this trial is for. This study is for children and young adults whose rare brain tumor has come back. Tumor tissue taken during surgery is tested right away. A special tumor board: A meeting where specialists look at one person's case together: surgeons, cancer doctors, the lab, and the people who read scans. You do not attend. What they decide is advice for your own doctor to talk through with you. See the glossary then uses those results to choose a treatment plan.
Where it stands. The study is checking whether this fast testing can be done and used to guide care. The answer is not in yet. The study has not reported results.
What this means, and what it doesn't
What it could mean: If this approach works, care teams may be able to choose treatment based on each person's tumor. The goal is to find the drugs most likely to help and least likely to harm. Someone who fits might ask their care team about this study.
What it doesn't mean: This does not mean there is a new treatment ready for you. A trial is a test, not proven care. Being in a trial is not a guarantee that it will help. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.